|
Current issue
Archive
Online First
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Special Issues
Instructions for authors
Publication charge
Editorial System
Submit your Manuscript
Open access 
|
2/2006
vol. 5 abstract:
The influence of transdermal hormone therapy on thromboembolic risk of women at menopausal period
Tomasz Pertyński
,
Grzegorz Stachowiak
,
Tomasz Stetkiewicz
,
Urszula Faflik
Prz Menopauz 2006; 2: 92–95
Online publish date: 2006/05/12
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
The present article is a short review of up-to-date reports on the influence of hormone therapy (HT) on the hemostatic elements responsible for thromboembolic complications, being one of the most threatening side effect of HT administration in women at menopausal period. Transdermal HT, in a far less degree than the oral type of this therapy does it, modifies (=increases) the vascular risk of thromboembolic events. Hence it should be a therapy of the first choice for women at increased risk of thromboembolic complications in circulatory system.
keywords:
thromboembolic risk, transdermal hormone therapy, coagulation, fibrinolysis, menopause |
 |
